专利检索 ap:"Rakeshri Ganesh KARKI" 第 1 页

1.

发明申请
Aminomethyl-Biaryl Derivatives Complement Factor D inhibitors and uses thereof 审中-公开
标题翻译：氨基甲基 - 二芳基衍生物补体因子D抑制剂及其用途

公开(公告)号：US20160145247A1

公开(公告)日：2016-05-26

申请号：US14904693

申请日：2014-07-17

申请人： David B. BELANGER , Stefanie FLOHR , Christine Fang GELIN , Keith JENDZA , Nan JI , Donglei LIU , Edwige Lilliane Jeanne LORTHIOIS , Rakeshri Ganesh KARKI , Nello MAINOLFI , James J. POWERS , Stefan Andreas RANDL , Olivier ROGEL , Anna VULPETTI , Taeyoung YOON

发明人： David Belanger , Stefanie Flohr , Christine Fang Gelin , Keith Jendza , Nan Ji , Rajeshri Ganesh Karki , Donglei Liu , Edwoge Liliane Jeanne LORTHIOIS , Nello Mainolfi , James J. Powers , Stefan Andreas Randi , Oliver Rogel , Anna Vulpetti , Taeyoung YOON

IPC分类号： C07D417/12 , C07C237/42 , C07D263/32 , C07D213/56 , C07D231/12 , C07D307/16 , C07D213/81 , C07D277/56 , C07D213/82 , C07D233/90 , C07D405/12 , C07C311/37 , C07D239/26 , C07D309/14 , C07D309/06 , C07C229/34 , C07D311/42 , C07D317/60 , C07D231/56 , C07D257/04 , C07D265/30 , C07D267/10 , C07D215/12 , C07D205/04 , C07D305/06 , C07C237/40

CPC分类号： C07D417/12 , C07C217/48 , C07C217/58 , C07C217/64 , C07C217/74 , C07C217/76 , C07C229/34 , C07C229/36 , C07C229/42 , C07C233/43 , C07C233/47 , C07C233/63 , C07C235/34 , C07C235/46 , C07C237/20 , C07C237/38 , C07C237/40 , C07C237/42 , C07C255/16 , C07C255/43 , C07C255/57 , C07C255/59 , C07C257/18 , C07C311/37 , C07C317/32 , C07C2601/02 , C07C2601/08 , C07C2601/14 , C07C2602/08 , C07C2602/10 , C07D205/04 , C07D213/56 , C07D213/81 , C07D213/82 , C07D215/12 , C07D231/12 , C07D231/56 , C07D233/90 , C07D239/26 , C07D257/04 , C07D263/32 , C07D265/30 , C07D267/10 , C07D277/56 , C07D305/06 , C07D307/16 , C07D309/06 , C07D309/14 , C07D311/42 , C07D317/60 , C07D405/12

摘要： The present invention provides a compound of formula (I), a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

摘要翻译： 本发明提供了式（I）化合物，本发明化合物的制备方法及其治疗用途。本发明还提供药理活性剂和药物组合物的组合。